{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:08:40Z","timestamp":1788588520383,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,16]]},"DOI":"10.7759\/cureus.43574","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T13:35:13Z","timestamp":1692192913000},"source":"Crossref","is-referenced-by-count":2,"title":["Myxedema Coma Precipitated by Sepsis in a Patient With a Complex Mental Health History"],"prefix":"10.7759","author":[{"given":"Mehul S","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh Kumar","family":"Pabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunaina","family":"Lohano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.je.2016.04.002","article-title":"Clinical characteristics and outcomes of myxedema coma: analysis of a national inpatient database in Japan","volume":"27","author":"Ono Y","year":"2017","unstructured":"Ono Y, Ono S, Yasunaga H, Matsui H, Fushimi K, Tanaka Y. Clinical characteristics and outcomes of myxedema coma: analysis of a national inpatient database in Japan. J Epidemiol. 2017, 27:117-22. 10.1016\/j.je.2016.04.002","journal-title":"J Epidemiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-7125(16)30091-8","article-title":"Myxedema coma: pathophysiology, therapy, and factors affecting prognosis","volume":"79","author":"Jordan RM","year":"1995","unstructured":"Jordan RM. Myxedema coma: pathophysiology, therapy, and factors affecting prognosis. Med Clin North Am. 1995, 79:185-94. 10.1016\/s0025-7125(16)30091-8","journal-title":"Med Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2006.09.003","article-title":"Myxedema coma","volume":"35","author":"Wartofsky L","year":"2006","unstructured":"Wartofsky L. Myxedema coma. Endocrinol Metab Clin North Am. 2006, 35:687-98, vii-viii. 10.1016\/j.ecl.2006.09.003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/0885066607301361","article-title":"Myxedema coma","volume":"22","author":"Kwaku MP","year":"2007","unstructured":"Kwaku MP, Burman KD. Myxedema coma. J Intensive Care Med. 2007, 22:224-31. 10.1177\/0885066607301361","journal-title":"J Intensive Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15277","article-title":"Myxedema coma: case report and literature review","volume":"13","author":"Elkattawy S","year":"2021","unstructured":"Elkattawy S, Dhanoa P, Kotys J, Fichadiya H, Eckman A. Myxedema coma: case report and literature review. Cureus. 2021, 13:e15277. 10.7759\/cureus.15277","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2019-317665","article-title":"Thyroid scintigraphy differentiates subtypes of congenital hypothyroidism","volume":"106","author":"Worth C","year":"2021","unstructured":"Worth C, Hird B, Tetlow L, Wright N, Patel L, Banerjee I. Thyroid scintigraphy differentiates subtypes of congenital hypothyroidism. Arch Dis Child. 2021, 106:77-9. 10.1136\/archdischild-2019-317665","journal-title":"Arch Dis Child"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000023462","article-title":"Hypothyroid myopathy with unusually high serum creatine kinase values","volume":"52","author":"Finsterer J","year":"1999","unstructured":"Finsterer J, St\u00f6llberger C, Grossegger C, Kroiss A. Hypothyroid myopathy with unusually high serum creatine kinase values. Horm Res. 1999, 52:205-8. 10.1159\/000023462","journal-title":"Horm Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10128","article-title":"Hypothyroid myopathy with a strikingly elevated serum creatine kinase level","volume":"26","author":"Scott KR","year":"2002","unstructured":"Scott KR, Simmons Z, Boyer PJ. Hypothyroid myopathy with a strikingly elevated serum creatine kinase level. Muscle Nerve. 2002, 26:141-4. 10.1002\/mus.10128","journal-title":"Muscle Nerve"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jecr.2021.100095","article-title":"Successful treatment of myxedema coma using levothyroxine and liothyronine in the setting of adrenal crisis and severe cardiogenic shock in a patient with apparent primary empty sella","volume":"22","author":"Elghawy O","year":"2021","unstructured":"Elghawy O, Hafey AC, McCartney CR, Steinman JR. Successful treatment of myxedema coma using levothyroxine and liothyronine in the setting of adrenal crisis and severe cardiogenic shock in a patient with apparent primary empty sella. J Clin Transl Endocrinol Case Rep. 2021, 22:100095. 10.1016\/j.jecr.2021.100095","journal-title":"J Clin Transl Endocrinol Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4158\/EP13460.OR","article-title":"A diagnostic scoring system for myxedema coma","volume":"20","author":"Popoveniuc G","year":"2014","unstructured":"Popoveniuc G, Chandra T, Sud A, et al.. A diagnostic scoring system for myxedema coma. Endocr Pract. 2014, 20:808-17. 10.4158\/EP13460.OR","journal-title":"Endocr Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14935","article-title":"Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association\/Society for endocrinology consensus statement","volume":"99","author":"Ahluwalia R","year":"2023","unstructured":"Ahluwalia R, Baldeweg SE, Boelaert K, et al.. Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association\/Society for endocrinology consensus statement. Clin Endocrinol (Oxf). 2023, 99:206-16. 10.1111\/cen.14935","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12824","article-title":"Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee","volume":"84","author":"Okosieme O","year":"2016","unstructured":"Okosieme O, Gilbert J, Abraham P, et al.. Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee. Clin Endocrinol (Oxf). 2016, 84:799-808. 10.1111\/cen.12824","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2018.07.013","article-title":"Therapeutic effects of mobile-based text message reminders for medication adherence in bipolar I disorder: are they maintained after intervention cessation?","volume":"104","author":"Menon V","year":"2018","unstructured":"Menon V, Selvakumar N, Kattimani S, Andrade C. Therapeutic effects of mobile-based text message reminders for medication adherence in bipolar I disorder: are they maintained after intervention cessation?. J Psychiatr Res. 2018, 104:163-8. 10.1016\/j.jpsychires.2018.07.013","journal-title":"J Psychiatr Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph181910213","article-title":"Interventions to improve medication adherence in patients with schizophrenia or bipolar disorders: a systematic review and meta-analysis","volume":"18","author":"Loots E","year":"2021","unstructured":"Loots E, Goossens E, Vanwesemael T, Morrens M, Van Rompaey B, Dilles T. Interventions to improve medication adherence in patients with schizophrenia or bipolar disorders: a systematic review and meta-analysis. Int J Environ Res Public Health. 2021, 18:10.3390\/ijerph181910213","journal-title":"Int J Environ Res Public Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1017\/S003329171700109X","article-title":"Promoting medication adherence among patients with bipolar disorder: a multicenter randomized controlled trial of a multifaceted intervention","volume":"47","author":"Pakpour AH","year":"2017","unstructured":"Pakpour AH, Modabbernia A, Lin CY, Saffari M, Ahmadzad Asl M, Webb TL. Promoting medication adherence among patients with bipolar disorder: a multicenter randomized controlled trial of a multifaceted intervention. Psychol Med. 2017, 47:2528-39. 10.1017\/S003329171700109X","journal-title":"Psychol Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/180387-myxedema-coma-precipitated-by-sepsis-in-a-patient-with-a-complex-mental-health-history","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:02Z","timestamp":1707508982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/180387-myxedema-coma-precipitated-by-sepsis-in-a-patient-with-a-complex-mental-health-history"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.43574","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,16]]}}}